Healthcare Global Enterprises Limited has informed the Exchange regarding Proceedings of Annual General Meeting held on September 25, 2025
HCG · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Healthcare Global Enterprises (HCG) held its 27th Annual General Meeting on September 25, 2025, from 5:00 PM to 6:00 PM IST via video conferencing, with 75 members attending online and 18 present at the corporate office. Non-Executive Chairman Dr. B.S. Ajaikumar presided over the meeting, while CEO Dr. Manish Mattoo presented key highlights of the company's financial performance, operations, and strategic initiatives for FY2024-25, with a focus on HCG's leadership position in oncology care. Four resolutions were transacted: (1) adoption of the audited financial statements for the year ended March 31, 2025, (2) re-appointment of Ms Anjali Ajaikumar Rossi as a director retiring by rotation, (3) approval of the appointment of Secretarial Auditors, and (4) ratification of remuneration to Cost Auditors for FY2025-26. Voting was conducted entirely through electronic means (remote e-voting and Insta-Poll at the AGM), with results to be disclosed to the stock exchanges and posted on the company's website in due course.
This is a routine regulatory disclosure confirming the AGM was held as scheduled with all four ordinary and special business items taken up. Investors should watch for the forthcoming voting results on each resolution, which could provide signals on shareholder sentiment, particularly around the director re-appointment and auditor ratifications. No immediate material impact on stock price is expected from this procedural filing.